Depression and type 2 diabetes: A causal relationship and mechanistic pathwayWael Y. Khawagi, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy et al.|Diabetes Obesity and Metabolism|2024Cited by 93
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspectiveMohammed Alrouji, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy et al.|Journal of Cellular and Molecular Medicine|2023Cited by 81
Pros and cons for statins use and risk of Parkinson's disease: An updated perspectiveHayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Αθανάσιος Αλεξίου et al.|Pharmacology Research & Perspectives|2023Cited by 75
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseasesMohammed Alrouji, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy et al.|Diabetology & Metabolic Syndrome|2023Cited by 72
Metformin and growth differentiation factor 15 (<scp>GDF15</scp>) in type 2 diabetes mellitus: A hidden treasureHayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb et al.|Journal of Diabetes|2022Cited by 60